NASDAQ · Consumer discretionary

Akso Health Group (AHG)

Akso Health Group reported revenue of $13.8M in fiscal 2026, down 6.4% from a year earlier. It posted a net loss of $18.7M. In fiscal 2026 capital spending exceeded operating cash flow by $12.8M. At March 31, 2026 it held $170.6K in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on July 23, 2026.

Watch AHG in 60 seconds

Price

$1.25

-2.45% on the day · November 10, 2026

52-week range $0.68 to $2.50

Market cap

$1.1B

Revenue (FY2026)

$13.8M

-6.4% year on year

Net margin

-135.0%

Key facts about Akso Health Group

Net worth: Akso Health Group has a market value (market cap) of $1.1B at the latest share price, and shareholders' equity of $180.9M on its balance sheet at March 31, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit: In fiscal 2026 revenue was $13.8M (-6.4% year on year), with a net loss of $18.7M.
Cash flow: In fiscal 2026 operations used $12.8M of cash.
Latest report: The latest periodic report (annual report (foreign issuer), 20-F) was filed with the SEC on July 23, 2026 and covers the period to March 31, 2026. Open on SEC EDGAR

What Akso Health Group does

Akso Health Group is registered with the SEC under industry code SIC 7389 (Services-Business Services, NEC). Its shares trade on NASDAQ under the ticker AHG.

Revenue and profit by year

Revenue

Net income

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal year	Revenue	Operating income	Net income	Diluted EPS	Free cash flow
2026	$13.8M	-$20.7M	-$18.7M	$0.01	-$12.8M
2025	$14.8M	-$166.3M	-$135M	$0.16	$1M
2024	$2.4M	-$8.6M	-$9.5M	$0.07	n/a
2023	$13.2M	-$14.3M	-$1.4M	-$0.02	n/a
2022	$6.3M	-$3.3M	-$16.9M	-$0.28	-$8.6M
2021	$1.8M	-$4.2M	-$34.8M	-$0.71	n/a

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Where AHG ranks in Consumer discretionary

Revenue$13.8M

#913 of 1077 in Consumer discretionary · Bottom 15%

Revenue growth-6.4%

#788 of 952 in Consumer discretionary · Bottom 17%

Net margin-135.0%

#952 of 968 in Consumer discretionary · Bottom 2%

Free cash flow margin-92.5%

#840 of 853 in Consumer discretionary · Bottom 2%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Consumer discretionary

Dividends

It paid out $19.5M in cash dividends, 353% of its net income.

Fiscal year	Per share	Paid out	Of profit
2019	n/a	$19.5M	353%

Per share as declared (or paid, where only that is reported), adjusted for stock splits the company itself restated. Yield is the latest fiscal year's dividend over the current price.

Latest SEC filings

What Akso Health Group has filed recently, newest first. Each links to the original document on SEC EDGAR.

July 23, 2026
Annual report (foreign issuer) 20-F · period to March 31, 2026Revenue fell 6.4% to $13.8M versus the prior year; diluted EPS $0.01 versus $0.16.
May 13, 2026
Foreign issuer update 6-K
March 23, 2026
Foreign issuer update 6-K
February 10, 2026
Foreign issuer update 6-K
August 14, 2025
Annual report (foreign issuer) 20-F · period to March 31, 2025Revenue rose 512% to $14.8M versus the prior year; diluted EPS $0.16 versus $0.07.
July 31, 2025
Form NT 20-F filing NT 20-F
May 22, 2025
Form F-3/A filing F-3/A
May 1, 2025
Foreign issuer update 6-K
March 28, 2025
Foreign issuer update 6-K
January 6, 2025
Form F-3/A filing F-3/A

Recent insider filings (Forms 3, 4 and 144): 7, the latest on April 6, 2026. Insider transactions on SEC

Insider trades

What the people running Akso Health Group did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)

last 90 days

Sold

last 90 days

All insider filings on SEC.gov · Where insiders are buying across the market

All filings on SEC EDGAR

Questions about AHG

What does Akso Health Group do?

Akso Health Group is a company in the Consumer discretionary sector, listed on NASDAQ as AHG. Its shares trade on NASDAQ under the ticker AHG.

What is Akso Health Group's net worth?

Akso Health Group has a market value (market cap) of $1.1B at the latest share price, and shareholders' equity of $180.9M on its balance sheet at March 31, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Akso Health Group profitable?

No. In fiscal 2026 it reported a net loss of $18.7M on revenue of $13.8M.

How much revenue does Akso Health Group make?

In fiscal 2026 Akso Health Group reported revenue of $13.8M. That is 6.4% less than a year earlier.

When did Akso Health Group last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on July 23, 2026. It covers the period to March 31, 2026.

Similar companies

Liquidity Services Inc

Compare AHG with

Compare AHG with any company

Follow AHG

Get an email when Akso Health Group files with the SEC: results, executive changes, material agreements and annual reports.

Where the numbers come from

Financial figures are the values Akso Health Group tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.